Skip to main content
Researchers at Waseda University developed a 4D printed vascular stent using micro stereolithography (PuSL) that activates at 37C body temperature.
Technology
1 min read

Researchers at Waseda University developed a 4D printed vascular stent using micro stereolithography (PuSL) that activates at 37C body temperature.

Originally reported by 3DPrint.com

Researchers at Waseda University developed a 4D printed vascular stent using micro stereolithography (PuSL) that activates at 37C body temperature. By optimizing polycaprolactone (PCL), the 10mm stents expand naturally without external heating. This innovation targets the 8 billion dollar stent market by simplifying procedures and reducing risk. These bioabsorbable structures eventually dissolve, eliminating long term foreign body presence. 🏥 #3DPrinting #MedTech #4DPrinting #AM

How This Connects

6 related events
  1. Same pattern

    3D Systems secures full-scope EU MDR certification for NextDent Jetted Denture Solution

  2. Same pattern

    Cairn Surgical has submitted a De Novo 510(k) application to the FDA for its Breast Cancer Locator (BCL) System, a patient-specific 3D printed surgical guide.

  3. Same pattern

    Align Technology is transitioning from indirect to direct 3D printing for its Invisalign aligner production, moving away from the traditional process of printing molds for vacuum-forming.

  4. Same pattern

    SprintRay has launched the Midas World Tour with Align, GC America, and Meisinger to integrate a chairside restorative workflow.

  5. Same pattern

    Lithoz is launching three high-performance ceramic materials - LithaLox, LithaCon zirconia, and LithaCon ATZ - engineered for industrial serial production.

  6. Same pattern

    UnionTech is scaling specialized medical additive manufacturing across dentistry, orthopedics, and surgical planning.

  7. This article

    Researchers at Waseda University developed a 4D printed vascular stent using micro stereolithography (PuSL) that activates at 37C body temperature.